TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biomedica Norden AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
392
|
407
|
412 |
| Financial expenses |
8
|
15
|
11 |
| Earnings before taxes |
1
|
-4
|
-5 |
| EBITDA |
45
|
56
|
50 |
| Total assets |
204
|
212
|
248 |
| Current assets |
122
|
81
|
72 |
| Current liabilities |
48
|
36
|
68 |
| Equity capital |
31
|
31
|
35 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
1
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
15.2%
|
14.6%
|
14.1% |
| Turnover per employee |
392
|
407
|
206 |
| Profit as a percentage of turnover |
0.3%
|
-1.0%
|
-1.2% |
| Return on assets (ROA) |
4.4%
|
5.2%
|
2.4% |
| Current ratio |
254.2%
|
225.0%
|
105.9% |
| Return on equity (ROE) |
3.2%
|
-12.9%
|
-14.3% |
| Change turnover |
-1
|
-6
|
1 |
| Change turnover % |
0%
|
-1%
|
0% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
0%
|
-50%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.